Q

Qiagen NV
D

QGEN

42.330
USD
0.22
(0.52%)
مغلق
حجم التداول
31,408
الربح لكل سهم
2
العائد الربحي
-
P/E
122
حجم السوق
9,407,588,520
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    A
    -3.140
    (-2.41%)
    127.100 USD
    BDX
    BDX
    -2.040
    (-0.90%)
    225.190 USD
    B
    BIO
    -30.13
    (-8.60%)
    320.14 USD
    D
    DGX
    3.615
    (2.30%)
    160.455 USD
    H
    HOLX
    1.040
    (1.34%)
    78.600 USD
    IDXX
    IDXX
    -2.54
    (-0.60%)
    421.30 USD
    I
    ILMN
    -7.180
    (-5.05%)
    135.110 USD
    L
    LH
    -3.029
    (-1.27%)
    235.180 USD
    P
    PKI
    1.920
    (1.57%)
    124.190 USD
    TMO
    TMO
    -19.95
    (-3.74%)
    516.18 USD
    المزيد
الأخبار

العنوان: Qiagen NV

القطاع: Healthcare
الصناعة: Diagnostics & Research
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).